Related Experiment Video

Updated: Jun 5, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

Establishment of interferon alpha-resistant hepatitis C virus using cell culture system

Huong T L Tran1, Yun-Sook Lim, Soon B Hwang

  • 1National Research Laboratory of Hepatitis C Virus, Ilsong Institute of Life Science, Hallym University, Anyang, Republic of Korea.

FEBS Letters
|December 29, 2010
PubMed

Insights

Researchers developed an interferon alpha (IFNα)-resistant hepatitis C virus (HCV) clone. Four mutations in the NS5A protein were identified as key to this resistance, aiding the study of treatment failure mechanisms.

Area of Science:

  • Virology
  • Hepatology
  • Molecular Biology

Background:

  • Hepatitis C virus (HCV) infection is a major global health concern.
  • Interferon alpha (IFNα) therapy has been a cornerstone for treating chronic hepatitis C, but treatment failure is a significant clinical challenge.
  • Understanding the molecular basis of IFNα resistance is crucial for developing more effective therapeutic strategies.

Purpose of the Study:

  • To investigate the molecular mechanisms of IFNα treatment failure in chronic hepatitis C.
  • To develop an IFNα-resistant HCV clone for further mechanistic studies.

Main Methods:

  • HCV JFH-1-infected Huh7.5 cells were treated with prolonged low-dose IFNα to select for resistant variants.
  • Genetic analysis was performed on the selected resistant HCV clone.
  • Wild-type JFH-1 was engineered to incorporate identified mutations into the NS5A gene.

Main Results:

  • A clone of HCV resistant to 100 U/ml IFNα was successfully selected.
  • Four specific substitution mutations were identified in the C-terminal coding sequence of the non-structural 5A (NS5A) protein of the resistant clone.
  • Introduction of these four mutations into wild-type JFH-1 conferred an IFNα-resistant phenotype.

Conclusions:

  • Four amino acid substitutions within the NS5A protein are implicated in conferring IFNα resistance to HCV.
  • The newly established IFNα-resistant HCV clone serves as a valuable tool for dissecting the molecular mechanisms of IFNα resistance in HCV infections.

More Related Videos

A Protocol for Analyzing Hepatitis C Virus Replication13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...